The San Diego company also lowered its financial guidance for 2025 in response to China’s import restrictions.

China imposed an import ban on Illumina’s gene sequencers in response to President Trump’s escalating tariffs and trade war ...

Illumina is reducing its forecast for this year’s financial performance and cutting $100 million in spending because China ...

In a sign it is willing to go further in responding to President Trump’s tariffs, Beijing blocked more American companies ...

Illumina shareholders received a warning shot. In response to President Trump’s initial tariff measures, the Chinese ...

Illumina has been barred from exporting its DNA sequencers to China, which closed | Illumina has been barred from exporting ...

Illumina (ILMN) responded to the March 4 notice from the China Ministry of Commerce that the company is not permitted to export sequencing ...

Today, Benzinga's options scanner identified 8 options transactions for Illumina. This is an unusual occurrence. The ...

Illumina Inc. (NASDAQ:ILMN), a leading provider of next-generation sequencing (NGS) technology with annual revenue of $4.37 billion, finds itself at a critical juncture as it navigates a shifting ...

Illumina (ILMN) is reducing its forecast for this year’s financial performance and cutting $100M in spending because China barred sales of its ...

Illumina on Monday lowered its annual forecast and said it plans to cut $100 million in spending after China announced a ban ...